Search Results
Feb 17, 2026, 06:00 ET IDEAYA Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
(B7H3/PTK7 bispecific TOP1 ADC): received investigational new drug (IND) clearance from the U.S. FDA in Q4 '25; expect to achieve first-patient-in (FPI) in Phase 1 dose escalation trial in Q1 '26;Dosing of the first patient with IDE034 will trigger a $5 million milestone payment from IDEAYA
More news about: IDEAYA Biosciences, Inc.
Feb 03, 2026, 10:00 ET 2025 CEO Pinnacle Awards - Winners Announced
annual CEO Pinnacle™ Awards. Chief Executives Council publishes the annual CEO Sentiment™ Study that quantifies a CEO Financial Performance Index™ (FPI), and the CEO Spending/Budget Index™ (SBI); along with the annual CEO Talent Study, and the upcoming CEO 2030: Predictions Panel. For more information,
More news about: Chief Executives Council
Jan 30, 2026, 00:33 ET FRONTERA ANNOUNCES DEFINITIVE AGREEMENT WITH GEOPARK TO DIVEST ITS COLOMBIAN E&P ASSETS PORTFOLIO FOR A FIRM VALUE OF $622 MILLION
Oleoducto de los Llanos Orientales S.A. ("ODL") crude oil pipeline, through Frontera's wholly owned subsidiary, Frontera Pipeline Investment AG ("FPI"), and the Company's 99.97% equity interest in Sociedad Portuaria Puerto Bahia ("Puerto Bahia"). The business combines an attractive growth
More news about: Frontera Energy Corporation
Jan 29, 2026, 13:00 ET 2025 Controller of the Year Awards - Winners Announced
publishes the annual CFO/Controller Sentiment™ Study, the Corporate Finance & Accounting Talent Study, the CFO/Controller Financial Performance Index™ (FPI); and produces the annual Controller of the Year™ Awards, Meet the Controller™ Interview Series, the Controllers for a Cause™ AICPA Scholarship Fund,
More news about: Controllers Council
Jan 26, 2026, 10:00 ET 2026 CFO/Controller Outlook & Sentiment Study Available Financial Performance Index (FPI) Trending
Index (FPI), and Spending-Budget Index (SBI). Sentiment predictions for key financial metrics are shared, along with forecasts for technology investment including AI, and hybrid work environment plans.Study highlights include a record high CFO/Controller Financial Performance Index (FPI) of 149% reinforces
More news about: Controllers Council
Jan 14, 2026, 23:52 ET HTX Hot Listings Weekly Recap (Jan 5-11): Binance Life and ZKP Lead the Rally as First-Mover Advantage Continues to Shine
FXS (Frax Finance): +110%, topping the weekly leaderboard. Frax Finance is a DeFi protocol offering three core products, FRAX, FPI, and frxETH, designed for yield generation, liquidity provision, and staking within the DeFi ecosystem.
More news about: HTX
Jan 14, 2026, 23:42 ET HTX Hot Listings Weekly Recap (Jan 5-11): Binance Life and ZKP Lead the Rally as First-Mover Advantage Continues to Shine
FXS (Frax Finance): +110%, topping the weekly leaderboard. Frax Finance is a DeFi protocol offering three core products, FRAX, FPI, and frxETH, designed for yield generation, liquidity provision, and staking within the DeFi ecosystem.
More news about: HTX
Jan 08, 2026, 09:30 ET High Liner Foodservice Launches Brand New Line of Fully Cooked Products
grocery and club stores. The Company also sells branded products to restaurants and institutions under the High Liner, Mirabel, Icelandic Seafood and FPI labels and is a major supplier of private label value-added seafood products to North American food retailers and foodservice distributors.High
More news about: High Liner Foods Incorporated
Dec 08, 2025, 16:43 ET Cereno Scientific Receives FDA Clearance to Initiate Global Phase IIb Trial of CS1 in Pulmonary Arterial Hypertension (PAH)
drug candidate CS1 for the treatment of pulmonary arterial hypertension (PAH). The FDA's decision enables Cereno to advance toward first patient in (FPI) in Q2 2026, with top-line data anticipated around Q4 2028, subject to enrollment timelines. The clearance follows constructive regulatory interactions
More news about: Cereno Scientific
Dec 08, 2025, 16:40 ET Cereno Scientific Receives FDA Clearance to Initiate Global Phase IIb Trial of CS1 in Pulmonary Arterial Hypertension (PAH)
drug candidate CS1 for the treatment of pulmonary arterial hypertension (PAH). The FDA's decision enables Cereno to advance toward first patient in (FPI) in Q2 2026, with top-line data anticipated around Q4 2028, subject to enrollment timelines. The clearance follows constructive regulatory interactions
More news about: Cereno Scientific
Nov 13, 2025, 23:26 ET FRONTERA ANNOUNCES STRATEGIC SPIN-OFF OF ITS COLOMBIAN INFRASTRUCTURE BUSINESS TO UNLOCK INTRINSIC VALUE
(3) Cash and Cash Equivalent refer to the portion of Frontera's portion of Cash and cash Equivalents from Frontera Pipeline Investment AG ("FPI") and Puerto Bahia's Cash & Cash Equivalents on September 30, 2025
More news about: Frontera Energy Corporation
Nov 13, 2025, 23:26 ET FRONTERA ANNOUNCES THIRD QUARTER 2025 RESULTS
listed on the TSX Venture Exchange under the trading symbol "OYL"; FEC ODL Holdings Corp., including its subsidiary, Frontera Pipeline Investment AG ("FPI", formerly named Pipeline Investment Ltd); Frontera BIC Holding Ltd.; Frontera Energy Guyana Holding Ltd.; Frontera Energy Guyana Corp.; and Frontera
More news about: Frontera Energy Corporation
Nov 12, 2025, 11:00 ET C-Suite 2026: Outlook & Sentiment Study
challenges, how will senior executives manage in 2026 and beyond? The annual study will identify a Financial Performance Index (FPI), along with expectations for financial metrics, spending and talent in 2026. And no sentiment study would be complete without the "What keeps you
More news about: Operations Council
Nov 10, 2025, 13:00 ET The 2026 CFO/Controller Outlook & Sentiment Study
financial controllers manage in 2026 and beyond? The annual benchmark study will identify a Financial Performance Index (FPI), along with expectations for financial metrics, spending and talent in 2026. And no sentiment study would be complete without the "What keeps you
More news about: Controllers Council
Nov 04, 2025, 08:01 ET Flexible Plan Investments launches FlexDirex, a first-to-market suite of single-stock ETF strategies in the U.S
Established in 1981, Flexible Plan Investments Ltd. (FPI) invests over $1.3 billion in assets for clients in its separately managed account business (as of Sept. 30, 2025). FPI is dedicated to preserving and growing wealth through dynamic risk management. FPI is a turnkey asset management program (TAMP), which
More news about: Flexible Plan Investments, Ltd
Nov 04, 2025, 06:00 ET IDEAYA Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update
RECIST 1.1 Go-forward dose selected for IDE397 and Trodelvy® clinical combination in MTAP-deleted urothelial cancer (UC), and FPI achieved in non-small cell lung cancer (NSCLC); next clinical update planned for a medical conference in the first half of 2026
More news about: IDEAYA Biosciences, Inc.
Nov 03, 2025, 08:30 ET Graphic Packaging International Joins Forces with Arbor Day Foundation to Restore Forests Worldwide
neighborhood temperatures by up to 10 degrees Fahrenheit. The Arbor Day Foundation's Forest Priority Index (FPI) and Nature Priority Index (NPI) tools will help guide Graphic Packaging's project selections. The FPI identifies forest regions where reforestation will have the highest impact on climate, biodiversity
More news about: Graphic Packaging Holding Company
Oct 30, 2025, 08:00 ET Pilatus Biosciences to Present New Preclinical Data Highlighting PLT012's Ability to Induce Durable Anti-Tumor Immunity Through Immunometabolic Reprogramming of the Tumor Microenvironment at SITC 2025 Annual Meeting
CEO of Pilatus Biosciences, added "Alongside a favorable GLP toxicology profile, these data support our planned Phase I study, with first patient in (FPI) targeted for Q1 2026." Details of the SITC poster presentation are as follows: Abstract
More news about: Pilatus Biosciences
Oct 23, 2025, 23:24 ET La FDA accorde la désignation Fast Track à AJ201, une thérapie inédite pour la maladie de Kenndy
dermatologie et des maladies immuno-inflammatoires, y compris des maladies rares telles que la maladie de Kennedy (SBMA) et la fibrose pulmonaire idiopathique (FPI). AnnJi s'engage à concevoir des traitements innovants qui améliorent la qualité de vie des patients souffrant de maladies chroniques
More news about: AnnJi Pharmaceutical Co., Ltd.
Oct 22, 2025, 23:08 ET La FDA otorga la designación de vía rápida para AJ201
dermatología y las enfermedades inmunoinflamatorias, incluyendo enfermedades raras como la enfermedad de Kennedy (SBMA) y la fibrosis pulmonar idiopática (FPI). AnnJi se compromete a desarrollar terapias innovadoras que mejoren la calidad de vida de los pacientes que padecen enfermedades
More news about: AnnJi Pharmaceutical Co., Ltd.
Oct 22, 2025, 16:15 ET Peoples Company Acquires Murray Wise Associates from Farmland Partners Inc.
solutions with offices across the nation, today announced the pending acquisition of Murray Wise Associates, LLC (MWA) from Farmland Partners Inc (NYSE: FPI). The transaction, effective November 15, 2025, includes the engagement of Peoples Company for the ongoing management of select non-core farmland assets.
More news about: Peoples Company
Oct 13, 2025, 05:25 ET AnnJi présente la percée clinique d'AJ201 au congrès 2025 de la World Muscle Society (WMS)
dermatologie et des maladies immuno-inflammatoires, y compris des maladies rares telles que la maladie de Kennedy (SBMA) et la fibrose pulmonaire idiopathique (FPI). AnnJi s'engage à concevoir des traitements innovants qui améliorent la qualité de vie des patients souffrant de maladies chroniques
More news about: AnnJi Pharmaceutical Co., Ltd.
Oct 13, 2025, 05:21 ET AnnJi presenta los avances clínicos del AJ201 en la WMS 2025
dermatología y las enfermedades inmunoinflamatorias, incluidas enfermedades raras como la enfermedad de Kennedy (SBMA) y la fibrosis pulmonar idiopática (FPI). AnnJi se compromete a desarrollar terapias innovadoras que mejoren la calidad de vida de los pacientes que padecen enfermedades
More news about: AnnJi Pharmaceutical Co., Ltd.
Oct 09, 2025, 10:00 ET 2025 CEO Pinnacle Awards - Call for Applicants
annual CEO Pinnacle™ Awards. Chief Executives Council publishes the annual CEO Sentiment™ Study that quantifies a CEO Financial Performance Index™ (FPI), and the CEO Spending/Budget Index (SBI). For more information, visit
More news about: Chief Executives Council
Oct 08, 2025, 20:16 ET Newmark acquiert RealFoundations, l'une des principales sociétés de conseil et de services gérés dans le domaine de l'immobilier
l'échelle mondiale. RealFoundations apporte une technologie avancée, une expertise en matière de conseil et une base de clientèle complémentaire composée de FPI, de gestionnaires d'investissement et de propriétaires de premier plan dans les secteurs des bureaux, du commerce de détail, de l'industrie, de l'immobilier
More news about: Newmark Group, Inc.